Sponsors

A statement on the new Omicron variant of SARS-CoV-2 (B.1.1.529)

Geoff Twist, Managing Director, Roche Diagnostics UK and Ireland has issued a statement on the new Omicron variant.

He said: “Our experts have analysed the publicly available sequences of the Omicron variant and we are assured that our tests to confirm COVID-19 infection continue to be accurate and reliable.
 
“While the news of the new Omicron variant is worrying for many, it’s important to remember that, like SARS-CoV-2, many viruses mutate over time. Accurate testing is already helping to build an understanding of the spread of this variant and in the coming days and weeks will provide important information to help us steer the course of action most likely to mitigate its impact.”

For further information you can read the full statement here.

Latest Issues

Lab Innovations

NEC, Birmingham
4-5 November, 2026

BAC Annual Scientific Meeting

Newcastle upon Tyne
13 November, 2026

DIA-MHRA Global Summit

Senate House, Malet Street, London, WC1E 7HU
16-17 November, 2026

POCT Innovators: Power to Disrupt - Clinical Diagnostics Now

Leonardo Royal Hotel, Oxford
16 November, 2025